ANN ARBOR - QuatRx Pharmaceuticals on Monday announced detailed primary endpoint results from Phase 3 clinical trial of Ophena (ospemifene tablets) to treat postmenopausal women with symptoms of vulvovaginal atrophy, a common condition associated with menopause. The successful trial brings QuatRx once step closer to commercialization. The study, the company said, successfully met all four
ANN ARBOR - The University of Michigan's Life Sciences Institute is launching a $10 million fund to shepherd promising biomedical discoveries from the lab bench to the marketplace, what biomedical researchers and venture capitalists call the Valley of Death. Called the Innovation Partnership, it uses philanthropic gifts to bridge this critical funding gap. More than
ANN ARBOR - MichBio has negotiated a special arrangement with the organizers of BioPharm America making its life science member companies eligible for a $200 registration discount for the BioPharm America 2008 conference Sept. 9-10 in Atlanta. Please note that you must state in the comment field within the online registration form that you are
ANN ARBOR - Biopharmaceutical company NanoBio Corporation has appointed David Stout, former president of Pharmaceutical Operations for GlaxoSmithKline Pharmaceuticals, to its board of directors. �??We are pleased to welcome David to our Board of Directors and look forward to benefiting from his guidance and contributions,�?� said James Baker Jr., M.D., chairman of NanoBio Corporation. �??David�??s
ALLEGAN - Perrigo Company has entered into a collaborative agreement with Cobrek Pharmaceuticals, a newly formed entity of Pentech Pharmaceuticals Inc., a privately owned company that specializes in the research and development of niche generic dosage forms. Pentech will contribute its ANDA filing for a generic equivalent to Luxiq(R) foam, a $34 million branded pharmaceutical
ANN ARBOR - University of Michigan spin out Tissue Regeneration Systems, a medical device company developing bioactive implants for bone and soft tissue regeneration, has closed a $2 million Series A round of financing, which was led by Venture Investors and joined by the founders of TRS. The company, a spin-out of the U-M and
ANN ARBOR - Nearly three years and thousands of hours later, patient safety received another boost at the University of Michigan Health System as the institution completed implementation of its online order entry system in the University Hospital and the Cardiovascular Center last week. Even before it was complete, the system - which has been
ANN ARBOR - Jeffrey Halter, M.D., director of the University of Michigan Geriatrics Center and Institute of Gerontology, has been named the 2008 Nascher/Manning Award recipient of the American Geriatrics Society �?? given to an individual with distinguished, life-long achievement in clinical geriatrics. Halter was cited by the AGS Board of Directors and the Awards
GRAND RAPIDS - The West Michigan Medical Device Consortium has gone live with its new web site, better to serve the more than 20 life sciences companies that have joined the group since it launched in December 2007. Established in the summer of 2007 through the support of the West Michigan Science & Technology Initiative,
ANN ARBOR - A multi-center trial led by the University of Michigan Health System finds short-term replacement of renal cell function with the bioartificial kidney speeds recovery and reduces a patient's mortality risk by 50 percent. The study - published in the Journal of the American Society of Nephrology - is one in a string